Trial Profile
A phase 2 study of neoadjuvant chemotherapy with gemcitabine, epirubicin and paclitaxel (Taxol)[GET] in locally advanced breast cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 04 Dec 2008
Price :
$35
*
At a glance
- Drugs Epirubicin (Primary) ; Gemcitabine (Primary) ; Paclitaxel (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 11 May 2007 New trial record.